The two most studied breast cancer predisposing variants of the CHEK2 gene are the 100delC deletion in the kinase domain in exon 10, and the 470 T > C (I157T) missense mutation in the fork-head-associated (FHA) domain in exon 3. This evidence concerns the gene CHEK2 and breast cancer.